webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Mal-PEG1-Val-Cit-OH

  CAS No.:   Cat No.: BADC-01271   Purity: ≥95% 4.5  

Mal-PEG1-Val-Cit-OH is a maleimide-based ADC linker with PEG spacer and Val-Cit dipeptide for enzymatic cleavage. Ideal for stable antibody conjugation and targeted payload release in antibody-drug conjugate development.

Mal-PEG1-Val-Cit-OH

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C20H31N5O8
Molecular Weight
469.49
Shipping
-20°C (International: -20°C)
Storage
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
Solubility
10 mm in DMSO
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
-20°C (International: -20°C)
Storage
Store at -20 °C, keep in dry and avoid sunlight.

Mal-PEG1-Val-Cit-OH, a versatile chemical linker essential in bioconjugation and drug development, finds diverse applications in various fields.

Antibody-Drug Conjugates (ADCs): Mal-PEG1-Val-Cit-OH plays a crucial role in the synthesis of antibody-drug conjugates, innovative cancer treatments that merge antibody specificity with potent cytotoxic drugs. This chemical serves as a robust linker that ensures controlled drug release specifically within the tumor microenvironment, enhancing the therapeutic efficacy of ADCs while minimizing harm to healthy tissues. The intricate interplay between antibodies and cytotoxic drugs mediated by Mal-PEG1-Val-Cit-OH underscores the precision of targeted cancer therapies.

Protein-Protein Conjugation: Within protein engineering, Mal-PEG1-Val-Cit-OH functions as a cross-linker, facilitating the connection between proteins or peptides for studying protein interactions and functions. This application is indispensable for generating complex biomolecules utilized in diagnostics and therapeutics. Through the strategic modification of proteins using this linker, researchers can bolster protein stability and activity while finely tuning their biological interactions. The versatile nature of Mal-PEG1-Val-Cit-OH in protein-protein conjugation underscores its significance in advancing biotechnological research.

Nanoparticle Functionalization: In the domain of nanotechnology, Mal-PEG1-Val-Cit-OH is instrumental in nanoparticle functionalization, enabling targeted delivery and controlled release of therapeutic agents. This capability is pivotal in constructing nanocarriers for drug delivery systems aimed at enhancing drug solubility and bioavailability. The inherent biocompatibility of Mal-PEG1-Val-Cit-OH ensures the stability of nanoparticles within biological environments, elevating their therapeutic effectiveness significantly.

Controlled Drug Release Systems: In the realm of pharmaceuticals, the adoption of Mal-PEG1-Val-Cit-OH in controlled drug delivery systems offers a method of tethering drugs to polymers or carriers for regulated drug release in response to specific stimuli like pH or enzymatic activity. This sophisticated mechanism ensures localized drug delivery precisely at the target site, enhancing treatment efficacy while reducing adverse effects.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Boc-amino-PEG3-SSPy | Aminooxy-PEG2-bis-PEG3-DBCO | DBCO-PEG4-SS-TCO | Mc-Leu-Gly-Arg | Hydroxy-PEG3-DBCO | Mal-C2-Gly3-EDA | Azido-PEG3-SSPy | Mal-PEG2-bis-PEG3-BCN | Methyltetrazine-SS-NHS | Hydroxy-PEG3-t-butyl ester | Mal-PEG1-Val-Cit-OH
Send Inquiry
Verification code
Inquiry Basket